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Synaptic target specificity, whereby neurons make distinct types of synapses with 
distinct target cells, is critical for proper brain function, yet the molecules driving this 
process are poorly understood. This work demonstrates that, contrary to established 
dogma, wildtype hippocampal mossy fiber (MF) filopodia do not synapse exclusively 
onto GABA neurons as previously thought, but instead synapse with similar frequency 
onto GABA neurons and CA3 neurons in developing mice. Moreover, loss of 
transmembrane cell adhesion molecule Kirrel3 selectively reduces MF filopodial 
synapses onto GABA neurons but not those made onto CA3 neurons nor DG-GABA en 
passant synapses. Consequently, Kirrel3 loss robustly increases CA3 neuron activity 
during development. In addition, rare Kirrel3 variants found in individuals with 
neurodevelopmental disorders reduce both cell-cell aggregation and specific synapse 
formation. In sum, the selective loss of MF filopodial synapses with GABA neurons 
likely underlies the hippocampal activity imbalance observed in Kirrel3 knockout mice 
and may impact neural function in patients with Kirrel3-dependent neurodevelopmental 
disorders. These findings demonstrate that subtle synaptic changes during development 
can greatly impact circuit function, solidify Kirrel3 as a bona fide synapse specificity 
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The brain is considered to be the most complex object in the known universe. 
Billions of cells must elegantly come together to create trillions of specialized cell-cell 
junctions called synapses that communicate every thought and action of our lives. There 
are many types of brain cells, or neurons, and they must form specific types of synapses 
between each other for proper brain function to occur. However, the rules governing how 
specific types of neurons form specific types of synapses are still relatively unknown. 
Moreover, disrupting one type of synapse but not others can alter the balance of neural 
activity within the brain, resulting in disease. Neurodevelopmental disorders are 
increasingly thought to be synaptopathies, or disorders of the synapse, but the 
fundamental molecular players failing to synthesize these precise circuit connections in 
disease are yet to be understood. One such fundamental player is Kirrel3, which regulates 
a particular kind of synapse within the hippocampus, a region of the brain necessary for 
learning and memory. In this introduction, I will present the concept of synapse 
specificity, followed by background on synaptic molecules and disease, and conclude 
with a primer on Kirrel3.     
 
What is synapse specificity? 
During development, an axon from one type of neuron must contact a dendrite 
from another type of neuron, and build a particular kind of synapse. This must occur 
trillions of times over to accomplish proper brain connectivity. These synapses can be 
categorized by their size, molecular composition, and localization. For instance, CA3 
pyramidal neurons within the hippocampus make three distinct types of excitatory 
synapses along their dendritic length; and each of these synapse types can be 
 3 
distinguished based on their morphology, presynaptic partner, and distinct molecular 
properties (Rawson, Martin, & Williams, 2017).  
One theory to explain this precise organization is the existence of molecular 
identification tags expressed by specific populations of neurons. These molecules are 
thought to also localize to particular regions of the neurons. These factors would instruct 
incoming axons to specific neuronal subregions to make specific types of synapses 
(Sperry, 1963). For example, a CA3 dendrite makes distinct synapses with axons from 
dentate granule (DG) neurons, CA3 neurons, and entorhinal cortex (EC) neurons in 
particular subregions. In support of Sperry’s theory, loss of cell adhesion molecule 
Cadherin-9 disrupts specifically DG synapses onto CA3 dendrites (Williams et al., 2011). 
This theory requires a diversity of synapse specificity molecules to act within particular 
temporal and spatial windows to specify each synapse type. By examining the molecular 
composition of synapses, it has been hypothesized that trans-synaptic cell adhesion 
molecule (CAM) families are good candidates for this role (Sanes & Yamagata, 2009).  
 
Synaptic cell adhesion molecules 
Cell adhesion molecules (CAMs) are proteins present on the cell surface that act 
to bind other cell surface molecules on other cells, or extracellular matrix molecules, to 
facilitate cell-cell binding. There are a multitude of CAMs expressed in various cell 
types. Cadherins, Leucine-Rich Repeat Transmembrane (LRRTM) proteins, neurexins, 
neuroligins, ephrins, teneurins, and many others are CAMs that have emerged as 
necessary players in synapse specificity (Basu, Taylor, & Williams, 2015; Leamey & 
Sawatari, 2014; Shapiro, Love, & Colman, 2007; Südhof, 2008; Südhof, 2017). These 
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proteins are composed of an extracellular domain that binds with transcellular partners to 
mediate cell-to-cell contacts, a transmembrane domain, and an intracellular domain 
thought to contact the necessary scaffolding molecules for synapse formation and 
function.  
In addition, these molecules can be alternatively spliced to generate even larger 
numbers of potential specificity molecules (Shapiro et al., 2007). For example, the Down 
syndrome cell adhesion molecule (Dscam) gene of the immunoglobulin superfamily of 
CAMs can express more than 38,000 different mRNAs via 95 alternative exons in flies, 
resulting in over 19,000 discrete extracellular domains. These numerous isoforms are 
developmentally regulated, can be found in distinct brain regions, and display isoform-
specific binding (Celotto et al., 2001; Wojtowicz et al., 2004). These characteristics are 
well-suited for molecules driving specific wiring of the brain. Thus, it is valuable to 
determine the molecules present in and around synapses that contribute to the brain’s 
ability to wire itself. 
 
Synaptic molecules and disease 
In the search for the etiology of neurodevelopmental disorders, hundreds of genes 
encoding for synaptic proteins have been identified as containing damaging copy number 
variations, deletions, and point mutations. These findings have inspired the theory that 
synapses and their dysfunction are the root cause of these disorders, now commonly 
called synaptopathies (Torres, Vallejo, & Inestrosa, 2017). Introduction of these genetic 
variants to stable systems are found to impact synapses in numerous ways. For example, 
Neuroligins (NLGN) are a set of five genes (NLGN1, 2, 3, 4, 4Y) encoding for 
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transmembrane cell adhesion postsynaptic proteins that serve as heterophilic partners for 
presynaptic Neurexins. These neuronal complexes are thought to mediate synapse 
development and/or remodeling in either excitatory or inhibitory neurons depending on 
the protein type (Chih, 2004; Rawson et al., 2017; Südhof, 2017). As both Neuroligins 
and Neuerxins are commonly linked with autistic disorders, mutations of these proteins 
have been investigated for altered function. When mutation NLGN3 R451C is transfected 
into COS cells and tested for surface biotinylation, reduced surface expression is 
observed. Subsequent cellular localization assays suggest the mutated protein is 
sequestered in the endoplasmic reticulum (Chih et al., 2004). Additionally, when 
overexpressed, wildtype Neuroligin localizes to dendritic spines and increases synapse 
number. However, when observing the mutated protein in cultured hippocampal neurons, 
very little is observed in dendritic spines. However, this again appears to be primarily 
because of cellular sequestration and not a defect in the ability to induce synapse 
formation as the few proteins able to make it to the spine do appear to recruit presynaptic 
elements (Chih et al., 2004). Thus, examining the point mutations found in individuals 
suffering from neurodevelopmental disease can identify critical protein domains as well 
as help us understand the root causes of neurodevelopmental disease. 
Another way synaptic protein alterations are thought to contribute to 
neurodevelopmental disorders is through perturbation of the excitation/inhibition (E/I) 
balance. A properly functioning brain reaches a stable circuit homeostasis between 
excitatory and inhibitory neurons to orchestrate precise neuronal firing patterns. If a 
population of excitatory or inhibitory synapses is lost or never formed, the E/I balance 
can shift, resulting in altered circuit function.  
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It was suggested in 2003 that autism spectrum disorders (ASD) might result from 
an increase in cortical circuit excitation via reduced inhibition (Rubenstein & Merzenich, 
2003). Since this proposition, evidence has been found for both increases and decreases 
in excitation over inhibition in relation to ASD. This suggests that rather than whole brain 
shifts towards excitation or inhibition, it is more likely that individual circuits are 
uniquely altered. It is also probable that primary circuit imbalances can drive secondary 
effects. For example, reduced excitation can lead to increased inhibition in one circuit, 
which then subsequently causes either increased or reduced excitation in a second circuit 
depending on the output from the originating circuit. This also illustrates how it can be 
difficult to distinguish primary circuit defects from a large pool of possible secondary 
effects (Nelson & Valakh, 2015). 
Thus, while E/I imbalances are now generally attributed to ASD, little is known 
about the specific source of the imbalance (Nelson & Valakh, 2015). Sadly, much of the 
evidence for such imbalances results from the use of imprecise methods such as FMRI 
(functional magnetic resonance imaging), which can only identify regions of gross 
imbalances. A single FMRI voxel contains more than a million synapses, thus precise 
circuit imbalances cannot be identified from this type of investigation. As a result, very 
little is known about specific circuit imbalances that could lead to disease, and even less 
about the molecules driving synapse formation and stabilization that organize these 
circuits. Therefore, it becomes critical to identify these molecules whose dysfunction 





Kirrel3 is a member of the immunoglobulin superfamily with five extracellular 
immunoglobulin domains, a single-pass transmembrane protein, and an intracellular 
domain with a single PDZ-binding motif located at its C-terminal tip. The PDZ-binding 
domain implies binding with a number of synaptic molecules including PSD-95 and ZO-
1 (Huber et al., 2003; Lee & Zheng, 2010). Three Kirrel family members exist called 
Kirrel 1, 2, and 3 corresponding to Neph1, Neph 3, and Neph2, respectively. Previously, 
these molecules had been examined for their ability to drive specific cell-cell contact 
through extracellular homophilic binding. Neph2/Kirrel3 has been investigated for its 
role in kidney slit diaphragm formation in which it is thought to interact intracellularly 
with ZO-1 and podocin to manage renal filtration by guiding podocyte foot processes 
(Gerke et al., 2005). In the brain, Kirrel3 was identified to regulate axonal fasciculation 
of odorant sensory neurons expressing the same odorant receptor onto specific glomeruli 
located within the olfactory bulb (Serizawa et al., 2006).  
In terms of synapses, Kirrel3’s ortholog SYG-1 has been studied for its role in 
directing specific synapse formation at HSN neurons in C. elegans. Here, it 
heterophilically binds SYG-2, otherwise known as nephrin. Loss of SYG-1 results in 
fewer synapses onto correct target cells and an increase in synapses onto improper targets 
(Shen & Bargmann, 2003; Shen, Fetter, & Bargmann, 2004). However, prior to our 





Kirrel3 and disease 
Kirrel3 is repeatedly linked to neurodevelopmental disorders through several copy 
number variations, deletions, and exonic missense point mutations identified in patients 
with autism spectrum disorders (Ben-David & Shifman, 2012; Cheng, Quinn, & Weiss, 
2013; De Rubeis et al., 2014; Iossifov et al., 2012; Kalsner et al., 2017; Michaelson et al., 
2012; Neale et al., 2012; Talkowski et al., 2012), intellectual disability (Bhalla et al., 
2008; Kaminsky et al., 2011; Talkowski et al., 2012), and Jacobsen syndrome (Guerin et 
al., 2012). Jacobsen syndrome is caused by the loss of the tip of chromosome 11 where 
the Kirrel3 gene is located. It is a developmental disorder that is often found to be 
comorbid with ASD, epilepsy, and intellectual disability (Guerin et al., 2012). Several of 
these Kirrel3 variants are proposed to be pathogenic; however, the nature of this 
pathogenicity is unknown. The exonic point mutations are found both in the extracellular 
and intracellular domains, and have low minor allele frequency (MAF) scores that 
identify them to be extremely rare variants within the population.  
 With these links to disease, Kirrel3 knockout mice have been independently 
generated and tested for behavioral abnormalities by three research groups (Choi et al., 
2015; Hisaoka et al., 2018; Prince et al., 2013). The first group examined Kirrel3 
knockout mice solely in coordination with a study on Kirrel3’s role in the olfactory bulb. 
They used a resident-intruder assay in which mice use urine pheromonal cues to respond 
aggressively to intruders in their territory and found Kirrel3 knockout mice displayed 
reduced male-male aggression (Prince et al., 2013). 
The next two studies were both more comprehensive and tested Kirrel3 knockout 
mice in a battery of behavioral assays. Choi et al. examined adult mice in the open field 
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test, elevated plus maze test, three-chamber social interaction test, buried food test, self-
grooming, novel object recognition test, Morris water maze test, contextual fear 
conditioning and extinction, contextual discrimination, radial arm maze test, and for 24 
hour movement (2015). They report Kirrel3 knockouts are hyperactive in a familiar 
environment, but not a novel environment. In addition, they find impaired novel object 
recognition indicating potential dysfunction in the hippocampus, the center for learning 
and memory in the brain (Choi et al., 2015). These tests were all completed in adult 
animals and the behavior of younger Kirrel3-deficient animals was not examined.   
 The most recent analysis of Kirrel3 knockouts by Hisaoka et al. (2018) examined 
the mice in the three-chambered social approach test, social recognition test, USV 
recording test (which examines alterations in ultrasonic vocalizations), open field test, 
light-dark transition test, rotarod test, elevated plus maze test, and ASR and PPI tests (a 
set of startle response assays that examine hearing defects). The researchers reported that 
adult Kirrel3-deficient animals spend far less time investigating novel mice in their home 
environment compared with wildtype mice, which they interpret as a defect in social 
investigation and social recognition memory. They also report several social 
communication defects. They find Kirrel3-deficient pups increase the number of 
ultrasonic calls upon separation from the mother, adult male mice make fewer calls to 
oestrous female mice, and in the resident-intruder assay, they find both Kirrel3 knockout 
male and female pairs make fewer calls to intruders, failing to establish a social 
dominance hierarchy. In agreement with Choi et al., they find increased hyperactivity 
within the home cage, but only during the light phase. Rearing was also found to be 
increased as was motor learning as tested by rotarod. They report Kirrel3-deficient 
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animals were less sensitive to both acoustic startle and pain stimuli tests as Kirrel3 
knockouts required greater stimuli in both to respond, which indicates deficits in hearing. 
Finally, their findings for the male-male aggression resident-intruder assay were 
consistent with the previous report from Prince et al. that described reduced aggression in 
Kirrel3 knockout animals (Hisaoka et al., 2018). 
 These studies support a role for Kirrel3 in both social behavior and memory. 
Thus, it will be valuable to examine Kirrel3 for altered synaptic function in brain regions 
known to regulate these behaviors, such as the hippocampus. In addition, human and 
mouse Kirrel3 are 98% identical and most, if not all, Kirrel3 variant sites are conserved. 
Connecting Kirrel3 gene variants to impaired neuronal function is imperative for 
clarifying how Kirrel3 contributes to healthy brain formation and for generation of 
specific and effective therapies to combat Kirrel3-dependent developmental disorders. 
 
Dissertation overview 
In this chapter, I have discussed synaptic specificity and the potential for a 
Kirrel3-specific mechanism of synapse formation important for social behavior and 
memory. In Chapter 2, I will describe research investigating the role of Kirrel3 in 
hippocampal synapse formation. In Chapter 3, I will describe research into how Kirrel3 
alters the synaptic landscape of mossy fiber filopodia as well as describe my findings 
regarding the profile of wildtype mossy fiber circuitry in developing animals. In Chapter 
4, I will describe my findings of how particular Kirrel3 variants alter Kirrel3 function. 
Finally, in Chapter 5, I will discuss potential mechanisms by which Kirrel3 acts within 
the hippocampus to drive synapse development. 
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Neurodevelopmental disorders are increasingly thought to be “synaptopathies” or 
disorders of the synapse. While many disease-associated changes are observed in the 
genome that encode synaptic proteins, we know little about how these mutations result in 
neural disease. Kirrel3 is a synaptic cell adhesion molecule and several protein coding 
variants of Kirrel3 are found in patients with mild to severe intellectual disability and 
autism spectrum disorders. We recently identified a role for Kirrel3 in hippocampal 
circuit formation. Kirrel3 loss reduces hippocampal mossy fiber DG-GABA filopodial 
synapses, which normally function to constrain CA3 pyramidal neuron activity. In 
addition, we found Kirrel3 knockout mice exhibit an increased excitation/inhibition ratio 
and evoked activity of CA3 neurons. Here, we examine rare Kirrel3 variants for altered 
function to identify critical regions of Kirrel3 and to determine if these variants are bona 
fide risk factors for disease. We find some Kirrel3 variants are unable to promote 
homophilic cell aggregation or induce synapse formation. These defects represent the 
first functional evidence that Kirrel3 variants could cause neural dysfunction and disease. 
 
Introduction 
Proteins involved in synaptic cell adhesion and synaptic scaffolding are the most 
prevalent genes identified in genome-wide association studies of neurodevelopmental 
disorders (Washbourne, 2014). This offers strong support to the current theory that most 
neurodevelopmental disorders are “synaptopathies” or disorders of the synapse. Studies 
of some synaptic proteins expressed by most neurons, such as Neurexins and Neuroligins, 
have led to valuable information about general synapse formation and function, and how 
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mutations found in disease can alter these processes (Sudhof, 2008; Zoghbi & Bear, 
2012). However, few of these synaptic molecules function between specific subtypes of 
neurons to synthesize precise synapse types. Neurodevelopmental diseases vary greatly 
and any therapeutics will need to target specific synapse defects while avoiding general 
synapse function. Thus, it is critical to identify specific sets of synapses, the molecules 
that govern their development, and how these molecules fail to function in disease.  
 Kirrel3 is a homophilic transmembrane cell adhesion molecule of the 
immunoglobulin superfamily. Exonic missense point mutations, copy number variations, 
and deletions of Kirrel3 are repeatedly found in individuals with autism spectrum 
disorders (ASD), mild to severe intellectual disability (ID), and Jacobsen’s syndrome 
(Ben-David & Shifman, 2012; Bhalla et al., 2008; Cheng, Quinn, & Weiss, 2013; De 
Rubeis et al., 2014; Guerin et al., 2012; Iossifov et al., 2012; Kalsner et al., 2017; 
Kaminsky et al., 2011; Michaelson et al., 2012; Neale et al., 2012; Talkowski et al., 
2012). These alterations are typically identified through mass whole exome sequencing of 
patients, and rarely are comorbidities noted. However, it is likely Kirrel3 defects 
represent a particular subpopulation of ASD/ID codisorders, which is a valuable 
distinction as it is estimated that 70% of ASD cases also present with ID (Tuchman & 
Rapin, 2002).  
Kirrel3 is composed of an extracellular region containing five immunoglobulin 
domains, a transmembrane domain, and an intracellular region terminating in a PDZ-
binding domain, which implicates interaction with a number of different proteins such as 
PSD-95 and ZO-1 (Figure 4.1A, left). In the hippocampus, Kirrel3 is specifically 
expressed in DG neurons and GABA neurons (Martin et al., 2015). Previously, we 
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identified a role for Kirrel3 in specific hippocampal synapse development between DG 
and GABA neurons within the mossy fiber circuit (Figure 4.1B). We find reduced DG-
GABA filopodial synapses in Kirrel3 knockout mice (Martin, Woodruff, Rawson, & 
Williams, 2017). In addition, we observed that loss of Kirrel3 results in an increase in the 
excitation/inhibition ratio and evoked activity of CA3 pyramidal neurons (Martin et al., 
2015). Behaviorally, Kirrel3 knockout mice are consistently found to be hyperactive and 
also have defects in developmental vocalization, novel object preference, and social 
interaction (Choi et al., 2015; Hisaoka et al., 2018; Prince et al., 2013; Völker et al., 
2018). Together, this work establishes Kirrel3 as a critical molecule for proper 
hippocampal mossy fiber circuit development. 
Mutations are identified spanning the protein in both the extracellular and 
intracellular domains. However, no study has examined Kirrel3 variants for reduced 
function. We sought to identify critical regions of Kirrel3 important for its function in 
synapse development through analysis of disease-associated point mutations. For this 
investigation, we selected several point mutations that span the protein coding sequence 
(Figure 4.1A, left). Human and mouse kirrel3 proteins are 98% conserved and the point 
mutations selected target conserved residues. Each variant has a low minor allele 
frequency (MAF) score, which identifies them to be extremely rare variants within the 
population.  
In addition, we questioned whether or not Kirrel3 functions during synapse 
development solely as a “molecular Velcro” to hold membranes together. This would 
imply that its extracellular region composed of IG domains is the critical component of 
the protein, and intracellular region is irrelevant to completing this function. To assess the 
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value of the intracellular domain, we chose to include in our assays a construct with the 
intracellular domain deleted (ICD). This protein is trimmed to four amino acids before 
the end of exon 14, just after the transmembrane domain (Figure 4.1A, right). 
Here, we examine Kirrel3 variants spanning the protein and discover defects both 
in cell aggregation and synapse formation. Our results present the first mechanistic 
insight to Kirrel3-mediated pathophysiology within the developing brain.  
 
Materials and methods 
Rats and cell lines 
Sprague dawley rats were ordered as timed pregnancies from Charles River. CHO 
cells from ATCC were kindly provided by the Nels Elde lab. All animals and 
experiments were maintained and conducted in accordance with the NIH guidelines on 
the care and use of animals and approved by the University of Utah IACUC committee. 
 
Kirrel3 point mutation cloning 
Standard PCR cloning was used to move Kirrel3 constructs to the pBos vector 
and add an extracellular FLAG tag after the signal sequence. Mutagenesis of the 
constructs was completed to introduce each point mutation. Separate constructs were 
synthesized to include mCherry-2A prior to each construct to achieve simultaneous 






Neurons: P0 rat cortical glia were cultured on PDL/collagen-coated coverslips to 
form a monolayer. One week later, P0 rat hippocampi were dissected in cold 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES)-buffered saline solution, 
incubated in papain for 30 min, dissociated, and plated to glial monolayers at 4–5 × 104 
cells/ml. All media was from Life Technologies (Carlsbad, CA, United States). Glia 
media: DMEM, 10% Fetal Bovine Serum (FBS), 75 mM glucose, and 
penicillin/streptomycin. Neuron-plating media: MEM, 10% horse serum, 50 mM glucose, 
0.250 mM pyruvic acid, 2 mM Glutamax, 100 U/ml penicillin, 100 μg/ml streptomycin. 
Neuron-feeding media: Neurobasal A, B27, 30 mM glucose, 0.5 mM Glutamax, 20 U/ml 
penicillin, 20 μg/ml streptomycin. Neuron transfections were done using the 
electroporation method (ECM830 model, BTX, Harvard Apparatus) at time of plating 
using 10-20 ug DNA or by using calcium phosphate transfection on DIV5 using 1-2 ug 
DNA. Cell lines: CHO media: F12K media, 10% FBS, and penicillin/streptomycin. Cell 
line transfections were done using polyethylenimine (PEI, Polysciences, Warrington, PA, 
United States) at a ratio of 5 μg PEI/1 μg DNA in culture experiments. 
 
CHO cell aggregation assay 
CHO cells were transfected with 5 ug DNA of each construct of interest using 
PEI. Forty-eight hours later, cells were washed with HEPES Mg2+ free (HMF) buffer 
(137 mM NaCl, 5.4 mM KCl, 1 mM CaCl2, 0.34 mM Na2HPO4, 5.5 mM glucose, 10 
mM HEPES, pH 7.4 adjusted with NaOH) and detached from the dishes using 0.01% 
trypsin in HMF. Detached cells were spun down, resuspended in HMF, counted, and 
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100,000 cells were pipetted into single wells of 24-well plates precoated with 1% BSA in 
HMF. Subsequently, the plates were placed on a nutator for 2 hours at 37°C. The cells 
were then fixed with paraformaldehyde (PFA) (2% final concentration) overnight, 
transferred to a 96-well glass bottom plate, and imaged in a Zeiss LSM 710 confocal 
microscope. The aggregation index was calculated by dividing the total fluorescence area 
in cell aggregates by the total fluorescence area in the well. Analysis was done using Fiji. 
 
Immunostaining 
All cultured cells were fixed in 4% PFA for 10 min, washed with phosphate-
buffered saline (PBS), and incubated in blocking solution (PBS with 3% bovine albumin 
and 0.1% Triton-X100) for 30 min. Primary antibody was diluted in blocking solution 
and incubated on cells for 1.5 hours. After three washes, secondary antibody was 
incubated for 40-60 min, washed, and cells were mounted for imaging using 
Fluoromount-G (Southern Biotech, Birmingham, AL, United States). For live labeling, 
cells were incubated with anti-FLAG antibody diluted 1:250 in serum-free media for 25 
min in the culture incubator. Cells were washed, fixed with PFA, and immunostained as 
above. For tissue sections, mice were transcardially perfused with 4% PFA. Brains were 
postfixed in 4% PFA overnight and 50 μm vibratome sections were cut. Sections were 
incubated in blocking solution (PBS, 3% BSA, 0.2% Triton-X100, 0.2% Saponin) for 
more than 1 hour and incubated in primary antibody at 4°C overnight while rocking. 
Secondary antibody incubation was done at room temperature for 2 hours. Sections were 




Primary antibodies were used as follows: goat anti-GFP 1:5000 (Abcam, 
Cambridge, MA, United States), chick anti-FLAG 1:250 livelabel, 1:1000 postfix (Gallus 
Immunotech, Cary, NC, United States), mouse anti-FLAG M2 1:5000 (Sigma), guinea 
pig anti-VGLUT1 1:10,000 (Millipore, Billerica, MA, United States), mouse anti-PSD95 
1:500 (NeuroMAB, UC Davis/NIH NeuroMAB Facility, Davis, CA, United States), 
rabbit anti-2A peptide 1:1000 (Millipore, Billerica, MA, United States), rabbit anti-FoxP1 
1:8000 (Abcam, Cambridge, MA, United States), mouse anti-GFP 1:100 (NeuroMab, UC 
Davis/NIH NeuroMAB Facility, Davis, CA, United States), goat anti-SPO 1:1000. All 
secondary antibodies were obtained from Jackson ImmunoResearch (West Grove, PA, 
United States) and used at 1:1000. 
 
Image analysis and statistics 
All experiments were conducted by an experimenter blind to condition. Sample 
sizes were based on previous experiments or power analysis. Statistics were calculated in 
Prism (GraphPad). All data were checked first for normality using the D’Agostino & 
Pearson normality test. If the data passed normality, t-tests or ANOVA were performed; 
if not, Mann Whitney or Kruskal-Wallis were performed. Post hoc multiple comparisons 
were run on ANOVA and/or Kruskal Wallis analyzed data to generate statistical 
significance between groups. Intensity levels of some images were adjusted for visibility 
in publication, but if so, the entire field of view and all comparable conditions were 
adjusted similarly. All images and conditions from the same experiment were collected 
and analyzed using the same confocal and analysis settings. 
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Variant selection 
Kirrel3 variants were selected for this study based on their stratification across the 
protein. Beginning with R40W, this point mutation is linked with intellectual disability 
and is located on the extracellular side before IG domain 1, within the signal sequence. 
R161H has been identified in ASD patients, and is predicted to fall in between IG 
domains 1 and 2. R205 is linked with ASD and is also found between IG domains 1 and 
2. All other point mutations selected are heterozygous, but R336Q was identified in a 
homozygous individual with ASD. In addition to extracellular point mutations, we also 
wanted to investigate mutations on the intracellular side. Thus, we selected both M673I 




Kirrel3 point mutations are present on the cell surface 
For Kirrel3 to function as a cell adhesion molecule, it is necessary for the protein 
to be trafficked to the cell surface. A mechanism thought to contribute to other 
synaptopathies is a failure of mutated protein to escape quality control in the ER and 
traffic to the cell surface (Chih et al., 2004). To test each mutated protein’s ability to 
make it to the cell surface, we co-transfected CHO cells, which do not have Kirrel3, with 
each of our variant constructs of interest and GFP to label the cell. Each Kirrel3 construct 
is tagged on the extracellular side with a Flag epitope (Figure 4.1A, left). We live labelled 
with a chick anti-Flag antibody to label extracellular Flag, and then after 
permeabilization, added a mouse anti-Flag antibody to label intracellular Flag (Figure 
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4.2A). Cells were selected by GFP and the ratio of extracellular to intracellular Flag 
calculated using Fiji. We observed no significant differences in the ratio of extracellular 
to intracellular Flag between any mutated proteins as compared with wildtype Kirrel3 
(Figure 4.2B). Therefore, all mutated proteins, and the ICD construct, successfully pass 
quality control within the ER and traffic to the cell surface (Figure 4.2C).      
 
Point mutations alter Kirrel3 homophilic binding 
Previously, we identified a role for Kirrel3 in hippocampal mossy fiber synapse 
formation between DG filopodia and GABA dendrites (Martin et al., 2017). We 
hypothesize that transcellular Kirrel3 homophilic binding promotes synapse development 
between these structures. Thus, it is possible that extracellular Kirrel3 point mutations 
could prevent homophilic binding and subsequent synapse development. In addition, it is 
known that intracellular domains are necessary for transcellular protein binding in 
molecules such as the classical cadherins. The intracellular domains between cadherins 
are highly conserved and bind actin via auxiliary actin-binding proteins to create a 
tension without which homophilic binding does not occur (Kannan & Tang, 2018). Thus, 
is will be interesting to see if intracellular Kirrel3 point mutations or our ICD construct 
also restrict homophilic binding.  
 To determine if Kirrel3 variants can bind in trans, we used the CHO aggregation 
assay in which we transfect CHO cells with our construct of interest and then float the 
cells in suspension to allow for aggregates to form (Martin et al., 2015). We synthesized 
constructs containing mCherry followed by a 2A peptide followed by our flag-tagged 
wildtype Kirrel3 protein or Kirrel3 with each variant of interest. This allows for us to see 
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simultaneous expression of mCherry in cells that also have our Kirrel3 constructs (Figure 
4.3A). We measured the total mCherry fluorescence in aggregate clumps over the total 
amount of mCherry fluorescence in the sample to create an aggregation index 
measurement. We observed clumping in our wildtype Kirrel3 samples, and we observed 
several mutated proteins that alter Kirrel3 aggregation (Figure 4.3B). Both R205Q and 
V731F significantly reduce Kirrel3 aggregation to levels near control. This offers a 
potential mechanism by which these two mutations could introduce disease and 
highlights two critical protein regions. Interestingly, our ICD construct actually tends to 
increase the ability of Kirrel3 to bind. This would imply the intracellular domain is not 
necessary for homophilic binding, yet one of the mutations that lessens cell aggregation is 
intracellular, V731F. This suggests a regulatory intracellular region exists, and 
extracellular protein-protein interactions are sufficient to induce cell aggregation.        
 
Mutated Kirrel3 proteins localize to synapses 
Overexpressed Kirrel3 protein localizes in and around synapses (Martin et al., 
2015). We questioned whether or not each Kirrel3 variant is capable of localizing to 
synapses. We transfected each point mutation into cultured hippocampal neurons using 
our mCherry-2A-Flag-Kirrel3 constructs. Neurons were selected by staining for 2A and 
synapses identified by the colocalization of vGlut1, a presynaptic marker, and PSD-95, a 
postsynaptic marker (Figure 4.4A). Surface expressed Kirrel3 protein and its variants 
were identified by live-labeling with Flag antibody (Figure 4.4A). We observed no 
differences in the number of Kirrel3 puncta present with colocalizing synaptic proteins, 
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nor the number of Kirrel3 puncta per dendrite examined, nor in synapse density (Figure 
4.4B-D). Thus, all Kirrel3 variants are properly trafficked in neurons to synapses. 
 
Kirrel3 promotes synapse development 
We hypothesize that homophilic binding of Kirrel3 is required for synapses to 
form between neurons expressing Kirrel3. To establish an in vitro assay of Kirrel3’s 
synaptic function, we adapted the previously published SPO assay (Williams et al., 
2011). Briefly, cultured hippocampal neurons largely retain their neuron-to-neuron 
specific connectivity as found in vivo (Williams et al., 2011). DG axons do not normally 
synapse onto CA1 neurons in vivo or in vitro. As Kirrel3 is endogenously expressed by 
DG neurons, we examined if Kirrel3 transfected into CA1 neurons could promote ectopic 
synapses to form between DG and CA1 neurons in culture. We reason that if ectopic DG 
synapses form onto Kirrel3-transfected CA1 neurons and not GFP-transfected neurons, 
then transcellular Kirrel3 signaling promotes synapse development. We can identify both 
CA1 neurons and DG synapses through combinatorial immunostaining with the 
following markers: CA1 neurons are identified by FoxP1 in developing cells (Figure 
4.5A) (Ferland et al., 2003), CA synapses are identified by staining with presynaptic 
marker VGlut1 (vesicular glutamate transporter 1), a population of inhibitory synapses 
are identified by staining with presynaptic marker SPO (synaptophysin II), and DG 
synapses are identified by colocalization of VGlut1 and SPO (Figure 4.5B).  
We first examined GFP-transfected neurons (Figure 4.5C) and Kirrel3 and GFP 
co-transfected neurons (Figure 4.5D) for the number of DG synapses made onto CA1 
neurons. While we observed no difference in the number of CA synapses (VGlut1+ only) 
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or inhibitory synapses (SPO+ only), we found a significant twofold increase in the 
number of DG synapses onto Kirrel3-transfected CA1 neurons as opposed to GFP-
transfected CA1 neurons (Figure 4.5E-G). We also observed no difference in the length 
of dendrite examined (Figure 4.5H). Total synapse density appears to increase in GFP 
and Kirrel3 co-transfected neurons, but the data do not reach significance (Figure 4.5I). 
These results support a role for Kirrel3 in targeted synapse development between neurons 
expressing Kirrel3. 
 
Point mutations eliminate Kirrel3’s ability  
to promote synapse development 
We next examined if our point mutation constructs could eliminate Kirrel3’s 
synaptic development function. This assay relies upon endogenous expression of full 
length Kirrel3 in DG neurons and thus tests for the ability of mutant Kirrel3 protein to 
bind with wildtype. We carried out the SPO assay for each point mutation of interest, co-
transfected with GFP. Surprisingly several point mutations showed no increased DG 
synapse density (Figure 4.6A). Of all the point mutations tested, only R336Q and M673I 
appear to recapitulate Kirrel3’s synapse development function. Also of interest is that the 
del-ICD construct is able to recapitulate Kirrel3’s synapse development function. Upon 
reviewing the difference in total synapse density, GFP and Kirrel3 cotransfected neurons 
display an increased number of synapses that reaches significance in this assay, likely due 
to an increase in the number of neurons analyzed. However, none of the point mutations 
reflect this increase (Figure 4.6B). These results indicate that both extracellular and 
intracellular mutations can hamper Kirrel3-mediated synapse development. However, a 
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power analysis based off of previous assay results suggests the sample size is not yet 
large enough to draw conclusions. While currently, 18-46 neurons were sampled per 
construct, our power analysis suggests 30 neurons per condition. We will increase our 
sample size to this value. 
 
Discussion 
Here we offer the first examination of rare Kirrel3 variants and their impact on 
cell function. In summary, we find Kirrel3 variants do not show defects in cell surface 
expression nor neuronal trafficking to synapses, but instead, we find specific variants 
prevent cell aggregation and targeted synapse development. Fascinatingly, variants that 
prevent cell aggregation are located both on the extracellular and intracellular regions of 
the protein and our findings highlight the critical need to understand the function of the 
Kirrel3 intracellular domain. There is also evidence to support that the extracellular 
region of Kirrel3 is cleaved by metalloproteases; however, this has not yet been observed 
in the brain (Gerke et al., 2005). Our results could indicate differences in extracellular 
cleavage, protein turnover, or the timing of surface expression mediated through other 
protein interactors. It is also unknown if Kirrel3 is able to bind in cis, which could 
implicate additional levels of regulation between same-cell proteins. Several synaptic cell 
adhesion proteins of the immunoglobulin superfamily have been found to dimerize and 
their lateral assembly is necessary for synaptic function (Fogel et al., 2011). 
Complete loss of the intracellular domain does not hamper cell aggregation; 
instead, it appears to enhance it. In addition, our ICD construct appears to mediate 
synapse development as well. We interpret these results as a loss of intracellular 
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regulation. Upon loss of regulatory elements, the molecule reverts into a simple 
“molecular velcro” that is able to promote synapse development through nonregulated 
homophilic binding. It will be of interest in the future to examine how loss of the 
intracellular domain affects protein management at the synapse. 
In addition, we find Kirrel3 induces targeted synapse development onto other 
neurons also expressing Kirrel3. This supports our previous finding that Kirrel3 is 
necessary for formation of DG-GABA filopodial synapses (Martin et al., 2017). It will be 
important in the future to identify types of neurons expressing Kirrel3 in other brain 
regions that may similarly use this molecule to orchestrate synapse development.  
Finally, we know Kirrel3 is an alternatively spliced protein with multiple isoforms 
found within the hippocampus. In particular, one form presents with a heavily truncated 
intracellular domain. This isoform is without the region that includes point mutation 
V731F, and is unable to increase DG synapses within the SPO assay (unpublished data). 
It would be of interest to add this region back into the protein to see if it rescues function. 
Overall, our work further establishes Kirrel3 as a critical molecule in proper brain 
development. Our study highlights critical regions of the Kirrel3 molecule and offers the 
first mechanistic insight into how Kirrel3 alterations could result in disease.  
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Figure 4.1: Kirrel3 is a transmembrane cell adhesion molecule in the 
immunoglobulin superfamily. (A) (left) Diagram of Kirrel3 protein and location of 
inserted FLAG tag, PDZ binding domain, and tested point mutations. Numbers identify 
separate immunoglobulin domains. (right) Diagram of synthesized Kirrel3 without the 
intracellular domain. (B) Diagram of hippocampal mossy fiber circuit location and 













Figure 4.2: Kirrel3 variants are surface expressed. (A) Diagram explaining surface 
expression assay. Extracellular protein (purple) and intracellular protein (beige) are 
shown. (B-C) Cultured CHO cells were cotransfected with GFP and each Flag-Kirrel3 
variant construct of interest and immunostained for indicated markers. Chick anti-FLAG 
antibody was added prior to fixation to label only surface Kirrel3. Mouse anti-FLAG 
antibody was added postfixation to label intracellular Kirrel3. Hoescht was used post-
immunostain to label cell nuclei. Cells selected by presence of GFP and Integrated 
Density (IntDen) measured in EC and IC channels. Extra/Intracellular Ratio calculated by 
dividing Extracellular IntDen by Intracellular IntDen. Quantification shown in (B) 
normalized to wildtype Kirrel3 shows no significant differences as measured by 
Kruskal-Wallis test. Line demarcates normalized value of 1. Mean ± SEM shown. N = 3 
cells per construct per culture, 3 cultures total. P value = 0.4410. Representative images 
shown for each construct in (C). Abbreviations: deleted intracellular domain, ΔICD; 



















Figure 4.3: Cell aggregation is altered by some Kirrel3 variants. (A-B) CHO cells 
were transfected with mCherry or mCherry-2A-Flag-Kirrel3 variant constructs and then 
tested for adhesion. Representative images show CHO cells transfected with mCherry or 
mCherry-2A-Flag-Kirrel3 and imaged for mCherry. (A) Aggregation index calculated by 
dividing the total mCherry fluorescence in aggregated cells by total mCherry 
fluorescence in the sample well. mCherry, R205Q, and V731F each showed reduced 
aggregation when compared to wildtype Kirrel3. Line demarcates normalized value of 1. 
(D) Mean ± SEM shown. N = 3 wells per construct per culture, 3 cultures total 
normalized to Kirrel3. **** indicates p < .0001, *** indicates p = .0004, * indicated p = 
.0109 by Kruskal-Wallis test followed by post hoc test to Kirrel3. Abbreviations: vector, 




Figure 4.4: Kirrel3 variants are similarly expressed at synapses. (A) Cultured 
hippocampal neurons were transfected with mCherry-2A-Flag-Kirrel3 variant constructs. 
At DIV21, Anti-FLAG antibodies were added prior to fixation to label only surface 
Kirrel3 (yellow). Cells were subsequently immunostained with vGlut1 (cyan) to mark 
presynaptic puncta, PSD-95 (red) to label postsynaptic puncta, and 2A (magenta) to 
identify transfected neurons. White arrows indicate synapses found by co-localization of 
vGlut1 and PSD-95 along transfected dendrites. No significant difference was found in 
the percent of synapses with Kirrel3 (B), the density of Kirrel3 puncta per 10um dendrite 
(C), nor the density of synapses per 10um dendrite (D). Mean ± SEM shown. N = 9-19 






Figure 4.5: Kirrel3 induces DG synapse formation onto transfected CA1 neurons.  
(A) Diagram showing a Kirrel3-transfected CA1 neuron with representative synaptic 
markers: vGlut1 identifying excitatory synapses (red), SPO identifying dg mossy fiber 
synapses and some inhibitory synapses (green), and vGlut1+SPO+ co-localized puncta 
identifying dg mossy fiber synapses (yellow). (B) P8 rat was perfused in 4% PFA and 
brain removed. Tissue was sliced into 100um slices and immunostained with FOXPI 
(red). (C-H) Cultured hippocampal neurons were electroporated with GFP (C) or co-
electroporated with GFP and Kirrel3 (D). At DIV14, cells were immunostained for GFP 
(purple), SPO (red), vGlut1 (green), and FoxP1 (not shown). White arrows indicate DG 
synapses identified by colocalization of vGlut1 and SPO (D). Kirrel3-transfected CA1 
neurons had significantly more DG synapses than GFP-transfected CA1 neurons (E). No 
significant differences were found in CA synapse density (F), spo+ only synapse density 
(G), or in the dendrite length examined (H). Total synapse density trends towards 
significance (I). Mean ± SEM are shown. N = 48 GFP transfected neurons and 38 GFP + 
Kirrel3 cotransfected neurons from three separate cultures normalized to GFP. ** 









Figure 4.6: Kirrel3 variants impair synapse formation (A-B) Cultured hippocampal 
neurons were electroporated with GFP or co-electroporated with GFP and Kirrel3 
construct of interest. At DIV14, cells were immunostained. Kirrel3-transfected CA1 
neurons had significantly more DG synapses than GFP-transfected CA1 neurons (A). 
ΔICD-transfected CA1 neurons had near significantly more DG synapses than GFP-
transfected neurons (A). No significant differences were found in total synapse density, 
though trends followed those observed in Figure 4.5 (B). Mean ± SEM are shown. N = 
18-46 neurons from two-four separate cultures normalized to Kirrel3. * indicates p </= 
.05 ** indicates p </= .01 by pairwise Kruskal Wallis test followed by an uncorrected 


























In Chapter 2, we described the first investigation of immunoglobulin superfamily 
member Kirrel3 at mammalian synapses. We found Kirrel3 is a homophilic, synaptic 
protein and loss of Kirrel3 results in a reduction of mossy fiber filopodia, the structures 
that facilitate DG synapses onto GABA neurons. Furthermore, we found that loss of 
Kirrel3 translated into perturbation of the excitation/inhibition ratio via increased activity 
of CA3 neurons. In Chapter 3, we looked closer at these mossy fiber filopodia by electron 
microscopy and found the loss of mossy fiber filopodia in Kirrel3 knockout mice resulted 
in fewer DG-to-GABA filopodial synapses during development, but no change in the 
number of en passant synapses. Here we also made several novel observations about 
wildtype mossy fiber filopodia including a change in their synaptic targets. We found that 
slightly more than 50% of mossy fiber filopodia synapse onto CA3 pyramidal neurons 
instead of 100% onto GABA neurons as previously described in literature (Acsády, 
Kamondi, Sıḱ, Freund, & Buzsáki, 1998). In Chapter 4, we looked closer at the functional 
regions of Kirrel3 and tested if rare Kirrel3 variants found in humans attenuate Kirrel3 
function. We found several point mutations that compromise Kirrel3 function in both cell 
aggregation and synapse development in culture.  
While my work in graduate school has provided answers to many of our initial 
questions about Kirrel3, many important questions remain and several more have been 
introduced. Is Kirrel3 just a cell adhesion molecule or is it doing more? What does 
Kirrel3 bind? How does Kirrel3 function at synapses? Why does Kirrel3 function at DG-
GABA filopodial synapses and not en passant synapses? In this chapter, I will propose 
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ideas for future studies of Kirrel3 and its role in neural circuit development to address 
these questions. 
 
How does Kirrel3 function at synapses? 
 Through our investigations of Kirrel3 in synapse formation, we observed 
reductions in filopodia density, filopodial synapse density, and CA3 neuron activity upon 
Kirrel3 loss. We also discovered defects in cell aggregation and synapse development in 
Kirrel3-transfected neurons upon introduction of Kirrel3 variants. However, these 
analyses were conducted without visualizing Kirrel3 and its exact location in vivo. We 
have some clues to Kirrel3 localization through overexpression experiments in which we 
used epitope-tagging to see Kirrel3 localized at synapses. However, to understand how 
Kirrel3 contributes to synapse formation over time, we need an in vivo examination of 
Kirrel3 localization.  
It would be informative to conduct immuno electron microscopy work to see if 
Kirrel3 localizes to en passant synapses as well as filopodial synapses. If Kirrel3 localizes 
to both synapses, it would suggest that a critical Kirrel3 partner protein is not present at 
en passant synapses, but present at filopodial synapses to promote synapse formation. 
Alternatively, en passant synapses could form earlier in development than filopodial 
synapses, at a time when Kirrel3 is not at high enough levels to promote synapse 
formation. In support, while the timeline of en passant synapse formation is unknown, en 
passant synapses visualized in our analyses were generally larger and more mature than 
filopodial synapses. Secondly, in our eLife publication, we included a synaptosome 
preparation examining Kirrel3 levels at postnatal day (P) 9, P21, and adult (Martin et al., 
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2015). Kirrel3 expression was low at P9 and increased at P21; however, we do not know 
about the expression of Kirrel3 at earlier time points. It is also possible that Kirrel3 does 
not localize to filopodial synapses at all, but instead orchestrates filopodial synapse 
formation through interactions with other proteins. For instance, Kirrel3 could interact 
with actin-binding proteins to motivate filopodia extension and motility to create a 
structure for synapse formation to occur. Or, Kirrel3 could manage synapses downstream 
of synapse formation and instead provide scaffolding for synapse stabilization. Time-
dependent localization assays will help narrow down these possibilities.   
 
What are Kirrel3’s binding partners? 
Particularly in Chapter 4, we questioned if Kirrel3 acted more as a pure cell 
adhesion molecule or if the intracellular domain also plays an important role in the 
molecule’s ability to promote synapse formation. We used a construct with the 
intracellular domain deleted (ICD) to determine if the extracellular IG domains were the 
only necessary factor for cell adhesion and synapse formation. While the ICD construct 
showed no defect in cell aggregation as expected, it instead aggregated more than other 
Kirrel3 constructs. Interestingly, in our SPO synapse formation assay, the ICD construct 
also showed no loss of function. This would support the idea that the intracellular domain 
is not necessary for synapse formation, and instead, Kirrel3 is acting purely as a cell 
adhesion molecule to hold the membranes together. However, in our analyses, we did 
find that one intracellular mutation did reduce Kirrel3’s synapse formation function. This 
contradicts the pure cell adhesion hypothesis, and instead leads us to think that there is an 
important regulatory region on the intracellular side that manages protein turnover or 
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posttranslational modification to impact Kirrel3 function. Upon deleting this domain, we 
have reduced the construct to a simple molecular glue.  
 These results highlight the need to identify the intracellular binding partners of 
Kirrel3. Now that we know some of the critical functional domains through our variant 
analysis, we can identify key Kirrel3 binding partners and subsequent downstream 
signaling pathways. Some in vitro support exists for Kirrel3 to bind other synaptic 
molecules by its PDZ domain such as calmodulin-associated serine/threonin kinase 
calmodulin-associated serine/threonin kinase (CASK), Fyn kinase, PICK1, and ZO-1 
(Bhalla et al., 2008; Harita et al., 2008; Höhne et al., 2011; Huber et al., 2003). Another 
study used a yeast two-hybrid screen to identify extracellular binding partners MAP1B 
and MYO16, and intracellular binding partners ATP1B1, UFC1, and SHMT2 (Liu et al., 
2015). They verified these partners by completing immunoprecipitations with transfected 
293 cells; however, their only evidence for interaction in neurons was through co-
localization in immunostaining experiments. It would be of value to complete an 
unbiased examination of Kirrel3 binding partners through proteomics. Completing pull 
downs followed by mass spectrometry would be a much more thorough and robust 
analysis of Kirrel3 binding partners.  
 Finally, we know from our aggregation assays that Kirrel3 can accomplish 
homophilic binding in trans. However, we do not know if Kirrel3 can bind in cis. 
Synaptic cell adhesion molecules such as SynCAM1 can oligomerize together in cis via 
its immunoglobulin domains. This lateral formation of SynCAM1 is shown to increase 
adhesion, promote clustering of axo-dendritic contact points in neurons, and removing 
this oligomerization reduces synaptogenesis (Fogel, Stagi, de Arce, & Biederer, 2011). 
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These findings could also be relevant for Kirrel3 and explain some of the defects 
observed in Kirrel3 variants in Chapter 4.  
 
What GABA neurons express Kirrel3? 
Earlier in this discussion, I suggested Kirrel3 might govern DG-GABA filopodial 
synapses but not en passant synapses because Kirrel3 might selectively localize to DG 
filopodia. Another qualifying factor are the types of GABA neurons that make en passant 
and filopodial synapses. There could be distinct populations of GABA neurons that 
synapse with DG neurons at en passants as opposed to filopodia, potentially governed by 
Kirrel3 expression. We did not examine in Chapter 3 if filopodia and en passant synapses 
ever occurred on the same GABA neuron. We can now return to this dataset to answer 
this question.   
In Chapter 2, we described the population of GABA neurons expressing Kirrel3. 
Using a number of antibodies for GABA neuron markers, we found that 67% and 19% of 
Kirrel3 positive interneurons in the CA3 region of the hippocampus colabel with 
Calbindin and Somatostatin, respectively. This identifies an unknown population of 
GABA neurons in which we do not know their synaptic partners nor other properties. 
Further analysis will need to be performed on these interneurons to determine their role 






Why do mossy fiber filopodia synapse with  
both GABA and CA3 neurons? 
Perhaps the most surprising finding we made was discovering that wildtype 
mossy fiber filopodia synapse with both GABA and CA3 neurons in development. This 
was unanticipated due to the fact that it is established in the field that DG filopodia solely 
synapse with GABA neurons to facilitate feed forward inhibition onto CA3 neurons. 
However, upon review, this finding is attributed solely to a single study in which only 
four filopodia were examined of 52.7% that were not observed to synapse with substance 
P receptor-positive GABA neurons (Acsády et al., 1998). Our findings highlight the 
importance of being open minded with regards to established dogma in the field. 
 It is possible that our observation of DG filopodia synapsing with both GABA 
and CA3 pyramidal neurons is a developmental phenomenon that disappears in 
adulthood. Our datasets capture young mice at P14 and we have not analyzed adult mice 
for defects. Further analysis will need to be done to discover if this phenomenon exists in 
adult animals as well. Regardless, it is a curious finding from the perspective of 
efficiency. Why might a DG axon utilize filopodial synapses to connect to CA3 neurons 
when thorny excrescences already exist to connect these structures? It is known that 
thorny excrescences, the postsynaptic spines connecting DG axons to CA3 dendrites, 
form early in development at P7 in rodents, prior to filopodia eruption at P14 (Wilke et 
al., 2013). Perhaps because filopodia are more plastic and motile, they can more easily 
manage shifting circuit needs between excitation and inhibition. But what feedback 
properties determine these shifts? Otherwise, some filopodial structures could also 
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function as extensions of the main bouton as a way of exploring the direction the main 
bouton will move in the near future.  
 Regardless, this finding makes our previous discovery of reduced filopodial 
density in Kirrel3 knockouts more significant. Previously we had assumed only 30% of 
DG-to-GABA filopodia were lost in Kirrel3 knockouts as observed by our DiI light 
microscopy experiments in Chapter 2. Instead, we find that 30% represents a much larger 
chunk of the DG-to-GABA filopodia as more than 50% of the filopodia contact CA3 




In this dissertation, I have presented the first examination of Kirrel3 at 
mammalian synapses and made a number of novel insights. These results will help guide 
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